SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
GUYER DAVID R

(Last) (First) (Middle)
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET

(Street)
WATERTOWN MA 02472

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/25/2019
3. Issuer Name and Ticker or Trading Symbol
EyePoint Pharmaceuticals, Inc. [ EYPT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
No securities are beneficially owned.
John Mercer, Attorney-in-Fact for Guyer David R 01/29/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24
POWER OF ATTORNEY
	
	Know all by these presents, that the undersigned hereby 
constitutes and appoints John Mercer, signing singly, and with full 
power of substitution, the undersigned's true and lawful attorney-in-
fact to:
	
	(1)	execute for and on behalf of the undersigned, in the 
undersigned's capacity as an officer and/or a director of EyePoint 
Pharmaceuticals, Inc., a Delaware corporation (the "Company"), 
Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities 
Exchange Act of 1934 and the rules thereunder;
	
	(2)	do and perform any and all acts for and on behalf of 
the undersigned which may be necessary or desirable to complete and 
execute any such Form 3, 4, or 5 and timely file such form with the 
United States Securities and Exchange Commission and any stock 
exchange or similar authority; and
	
	(3)	take any other action of any type whatsoever in 
connection with the foregoing which, in the opinion of such attorney-
in-fact, may be of benefit to, and in the best interest of, or 
legally required by, the undersigned.
	
	The undersigned hereby grants to each such attorney-in-fact 
full power and authority to do and perform any and every act and 
thing whatsoever requisite, necessary, or proper to be done in the 
exercise of any
 of the rights and powers herein granted, as fully to 
all intents and purposes as the undersigned might or could do if 
personally present, with full power of substitution or revocation, 
hereby ratifying and confirming all that such attorney-in-fact, or 
such attorney-in-fact's substitute or substitutes, shall lawfully do 
or cause to be done by virtue of this power of attorney and the 
rights and powers herein granted.  The undersigned acknowledges that 
the foregoing attorneys-in-fact, in serving in such capacity at the 
request of the undersigned, are not assuming, nor is the Company 
assuming, any of the undersigned's responsibilities to comply with 
Section 16 of the Securities Exchange Act of 1934.
	
	This Power of Attorney shall remain in full force and 
effect until the undersigned is no longer required to file Forms 3, 
4, and 5 with respect to the undersigned's holdings of and 
transactions in securities issued by the Company, unless earlier 
revoked by the undersigned in a signed writing delivered to the 
foregoing attorneys-in-fact.
	
	IN WITNESS WHEREOF, the undersigned has caused this Power 
of Attorney to be executed as of this 25th day of January, 2019.


					/s/ David R. Guyer		
					-------------------
					Signature

					    David R. Guyer
					-------------------		
	 				Print Name